Duquesne's Druckenmiller Dumps Nvidia and Palantir, Piles into Teva Pharmaceutical Industries Ahead of 2026

Billionaire Stanley Druckenmiller sold his fund's stakes in Nvidia and Palantir, two AI darlings, and instead invested in Teva Pharmaceutical Industries, one of Wall Street's hottest drug stocks, for five consecutive quarters. Druckenmiller's decision to exit Nvidia and Palantir ahead of 2026 may not be solely due to profit-taking, as the stocks have experienced significant growth since the beginning of 2023. The shift in Druckenmiller's investment strategy highlights the importance of staying vigilant in the rapidly evolving tech landscape.